First REal-Life Evaluation of Darifenacin in Overactive Bladder Patients During 3 Months.
Phase of Trial: Phase IV
Latest Information Update: 28 Apr 2015
At a glance
- Drugs Darifenacin (Primary)
- Indications Overactive bladder
- Focus Adverse reactions
- Acronyms FREEDOM
- Sponsors Bayer
- 20 Dec 2011 Actual end date changed from Oct 2008 to Feb 2009 as reported by ClinicalTrials.gov.
- 19 Jun 2009 New trial record